Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_assertion type Assertion NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_head.
- NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_assertion description "[NY-BR-1 expression was more frequent in estrogen receptor-positive and lymph node-negative primary carcinomas (P < 0.05 each) and was more common in grade 1 (77%) than in grade 2 (63%) or grade 3 (50%) carcinomas (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_provenance.
- NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_assertion evidence source_evidence_literature NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_provenance.
- NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_assertion SIO_000772 16675566 NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_provenance.
- NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_assertion wasDerivedFrom befree-20150227 NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_provenance.
- NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_assertion wasGeneratedBy ECO_0000203 NP960690.RA4x8X4HJdHV5z2Dfc3iaJeWKJgYiS9YiguvpyOGNKgVo130_provenance.